학술논문
Treatment to Target Using Recombinant Interleukin-1 Receptor Antagonist as First-Line Monotherapy in New-Onset Systemic Juvenile Idiopathic Arthritis: Results From a Five-Year Follow-Up Study
Document Type
Article
Author
Source
In: Arthritis and Rheumatology . (Arthritis and Rheumatology, July 2019, 71(7):1163-1173)
Subject
Language
English
ISSN
23265205
23265191
23265191